Released Sep 14, 2015, after the close
10-Q filed Sep 14, 2015, 45 days after period end · 0001354488-15-004283
Q3 2015 · 10-Q
Revenue—
Net Income$453.97K$453.97K −24.0% vs Q3 2014+26.5% vs Q2 2015
EPS Diluted$0.02$0.02 −24.0% vs Q3 2014+26.7% vs Q2 2015
Gross Profit$2,046,237−6.1%
Operating Income$495,322−29.1%
Operating Cash Flow-$348,936N/M
Free Cash Flowderived-$382,032N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Net Income | $453.97K | $597.06K | $1.25M | $1.28M |
| EPS Diluted | $0.02 | $0.03 | $0.05 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR